gene therapies
8 Trends to Watch in the Cell and Gene Therapy Market
An increase in rare/ultra-orphan treatments, along with a boom in cell and gene therapies and ambulatory infusion ...
DECEMBER 17, 2024
CGTs ‘a Big Deal for Pharmacy,’ So Getting Payment Right Is Crucial
At millions of dollars per dose, CGT treatments pose demanding procurement and reimbursement challenges for U.S. ...
JULY 17, 2024
Who Will Pay for Sickle Cell Gene Therapy?
The December 2023 FDA approval of the first two gene therapies to treat sickle cell disease was a giant step ...
FEBRUARY 26, 2024
FDA Approves Casgevy for Beta-Thalassemia
The FDA approved the cell-based gene therapy Casgevy for transfusion-dependent beta-thalassemia.
JANUARY 18, 2024
Load more